As a clinician and a trusted resource for families, healthcare professionals are essential in making sure patients and their families are informed about health risks and care. By starting conversations about DS-AD, healthcare professionals can help individuals with Down syndrome and their families better understand Alzheimer’s disease risks, prepare for the future, and learn about opportunities in research and clinical trials. Doctors, clinicians, and other healthcare professionals can make a real difference in the lives of individuals with Down syndrome and their caregivers.
This page provides healthcare professionals with:
Access to free clinical education opportunities to learn more about DS-AD through CARE Down Syndrome, including the foundational course and the Alzheimer’s Disease reference article
Resources to share with families and caregivers to support conversations about DS-AD
Information on DS-AD research and clinical trial opportunities, keeping you informed and enabling you to guide families interested in learning more
Looking for additional information or resources? Contact us at health@ndss.org.
...In a recent survey of 200 caregivers, nearly 91% reported they had never discussed Down syndrome–associated Alzheimer’s disease (DS-AD) in detail with a healthcare professional.
We can solve this together.
Resources for Healthcare Professionals
DS-AD Tools and Resources for Professionals
GLOBAL Medical Care Guidelines for Adults with Down Syndrome
Evidence-based medical recommendations to support clinicians in their care of adults with Down syndrome.
Latest Research Publications
Latest NDSS peer-reviewed publications related to Down syndrome.
Guidance and Resources for Professionals
A knowledge hub about dementia and neuroatypical conditions for clinicians, researchers, caregivers, and individuals.
Specific Resources Related to Dementia and Down syndrome
Screening tools, guides, and other resources for healthcare professionals.
Ready to Support Families Interested in Research?
DS-AD Research Studies
Nicotinamide Adenine Dinucleotide (NAD) Augmentation to Prevent or Reverse the Progression of Alzheimer's Disease in People with Down Syndrome
Researchers are trying to find out if a study drug may help prevent or delay Alzheimer's disease in adults with Down syndrome. Adults with Down syndrome (18+), with a caregiver of 10 hours of contact per week, and speak English as a primary language can participate. Participants will take daily NMN or placebo tablets for 28 days over 8 in-person visits. Compensation is provided.
Contact: researchdownsyndrome@mgh.harvard.edu | Massachusetts General Hospital
A Study to Evaluate Mivelsiran in Adult Participants with Early Stage DS-AD
Researchers are testing an investigational medication called mivelsiran. They want to see if it's safe and if it helps with Alzheimer’s disease symptoms in people with Down syndrome. You might be able to join if:
- You are between 40 and 55 years old.
- You have Down syndrome with early-stage Alzheimer's disease.
- You have a Study Partner who can come to study visits with you.
- You are able to have tests like injections, MRIs, and others.
Contact: https://www.applaudsclinicalstudy.com/ | Alnylam Pharmaceuticals, Incorporated